Early Use of Vasopressin in Post-Fontan Management
Status:
Completed
Trial end date:
2019-01-28
Target enrollment:
Participant gender:
Summary
This is an investigator initiated, prospective, single-center, double-blinded, randomized,
placebo-controlled trial of post-operative low dose vasopressin infusions as an early
treatment of low systemic perfusion in pediatric patients following Fontan palliation.